Acorn Creek Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Buy
2,251
+201
+10% +$46.8K 0.2% 33
2025
Q4
$424K Buy
2,050
+619
+43% +$122K 0.15% 39
2025
Q3
$265K Buy
+1,431
New +$245K 0.1% 57
2025
Q2
Sell
-1,317
Closed -$218K 78
2025
Q1
$218K Sell
1,317
-287
-18% -$44.9K 0.11% 70
2024
Q4
$232K Sell
1,604
-107
-6% -$16.6K 0.12% 66
2024
Q3
$277K Buy
+1,711
New +$273K 0.15% 51
2024
Q2
Sell
-1,685
Closed -$267K 69
2024
Q1
$267K Buy
1,685
+21
+1% +$3.34K 0.17% 53
2023
Q4
$261K Buy
+1,664
New +$255K 0.12% 63

Other funds holding JNJ

Acorn Creek Capital's JNJ Position: Q1 2026 in Review

Acorn Creek Capital increased its Johnson & Johnson (JNJ) stake by 9.8% in Q1 2026, buying an estimated $46.8K and bringing the position to 2,251 shares worth $550K. The position accounts for 0.2% of the portfolio, ranked #33.

Acorn Creek Capital first reported a position in JNJ in Q4 2023 and has held it in 8 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Acorn Creek Capital held 2,251 shares of Johnson & Johnson worth $550K as of Q1 2026.
  • Acorn Creek Capital bought 201 Johnson & Johnson shares in Q1 2026, an estimated $46.8K.
  • Johnson & Johnson made up 0.2% of Acorn Creek Capital's portfolio in Q1 2026, its #33 holding.
  • Acorn Creek Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 8 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Acorn Creek Capital's 13F filing for Q1 2026, filed 12 May 2026.